InspireMD launches CGuard Prime carotid stent system in US after FDA PMA approval

InspireMD, Inc.

U.S. commercial launch of CGuard Prime carotid stent system after FDA PMA approval.
Device features dual-layer design with MicroNet mesh (20 µm PET) and SmartFit technology.
CEO Marvin Slosman notes double-digit market share in >30 countries; U.S. team assembled.
First commercial case performed by Dr. D. Chris Metzger at OhioHealth; Ballad Health involved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.